While Alzheimer’s disease often is in the spotlight as the most common cause of dementia in older adults, the “ADRDs” or Alzheimer’s disease-related dementias, are also a vital and urgent part of our research agenda. Please join us for the next step in discussing and setting dementia research priorities, the 2019 Alzheimer’s Disease-Related Dementias (ADRD) Summit, fast approaching on March 14 and 15.
This Summit, hosted by our colleagues at the National Institute of Neurological Disorders and Stroke (NINDS), is an important event bringing together top American and international experts to shine the spotlight on AD-related dementias, defined in the National Plan to Address Alzheimer’s Disease as frontotemporal disorders (FTD) and Lewy body (LBD), mixed, and vascular dementias. You can have a front-row seat by watching the Summit on videocast.
What’s new at the 2019 Summit?
Part of the National Plan To Address Alzheimer’s Disease, the 2019 Summit complements the 2018 NIA Alzheimer’s Disease Research Summit and the National Research Summit on Care, Services and Supports for Persons With Dementia and Their Caregivers. This year’s Summit will feature sessions on the following topics:
- Multiple Etiology Dementias
- Lewy Body Dementias
- Vascular Contributions to Cognitive Impairment and Dementia
- Frontotemporal Degeneration
- Health Disparities in AD/ADRD
- Nomenclature in AD/ADRD
- Emerging Topics
The Emerging Topics session is new to the ADRD Summit and in 2019 will cover two major areas: traumatic brain injury (TBI) and AD/ADRD risk and hippocampal sclerosis/TDP-43 pathology in common dementias.
Also new in 2019 is the ADRD Trainee Travel Scholarship Program. This program is designed to increase training and contact with peers regarding the complex realities of the basic and clinical science of AD/ADRD. There are 21 scholarship recipients, including graduate, postdoc, and medical trainees. The group, which is diverse in both ethnicity and gender, will meet with leading scientists before the Summit, attend the Summit, and participate in debriefing discussions afterward.
The Scientific Chair for the Summit, Dr. Julie Schneider from Rush University Medical Center, will be one of the featured speakers, along with a number of prominent researchers. You can see the full agenda and list of speakers here.
What are the Goals of the 2019 Summit?
Since October of 2018 working groups that function as think tanks for each of the seven sessions of the Summit have been meeting to discuss and weigh both progress since the ADRD Summit 2016, as well as the most critical remaining scientific questions that must be answered as soon as possible to facilitate the discovery of better treatments or even cures for dementia. At the Summit, these working groups will present the deliverables that are required of them – new and updated recommendations for research in ADRD for the next five to 10 years – for input from all stakeholders, public, research, NGO, government, industry, and others for their candid input. There will be a lot of open microphone time to facilitate this feedback. Rationale for the recommendations proposed and presented will be based on the state of the field and progress made, much of which will be presented, on the research recommendations developed by previous Related Dementias Summits held in 2013and 2016.
Don’t miss it!
As we work toward our ultimate goal of hope for all kinds of dementia by 2025, collaboration and cross-pollination will be essential. The 2019 ADRD Summit is a capital opportunity to explore new questions, take stock of previous research progress, and advance the state of dementia science forward. Be sure to tune in to the videocast on March 14 and 15.Alzheimer’s DiseaseDementiaMeetingsStrategic Directions